Pfizer has a shockingly long history of engaging in illegal activities and human experimentation

Big Pharma company Pfizer has repeatedly engaged in inhumane and illegal activities in its history, including acts of fraud, corruption and even human experimentation disguised as vaccine trials.

An investigative journalist writing about censored subjects under the pseudonym “Kanekoa the Great” noted on his Substack blog that one of the greatest cultural transformations to occur in the past nearly three years is the complete rehabilitation of the image of Big Pharma companies and their newfound glorification for supposedly being responsible for saving humanity from the Wuhan coronavirus (COVID-19) pandemic.

“An industry plagued by decades of fraud, corruption and criminality managed to quickly rebrand itself as the savior of humanity during the COVID-19 crisis. But nothing inherently changed. Big Pharma still values shareholders’ profits more than people’s lives,” Kanekoa the Great wrote. (Related: Pfizer’s business model is to create the sickness and sell the “cure.”)

For evidence of Pfizer’s history of engaging in illegal activity that leads to the deaths of hundreds, Kanekoa the Great said to look no further than Nigeria.

In the northern Nigerian city of Kano, Pfizer in 1996 administered an experimental drug to 200 children whose parents never knew that their kids were subjected to a clinical trial. Pfizer did not obtain consent or inform any of the children or their parents that they were the subjects of an experiment. The pharma company did not even inform the recipients that the drug has not been approved for wider use.

Eleven of the children died. Dozens more of the children suffered severe adverse effects, including brain damage and organ failure.

As a result of criminal and civil suits, Pfizer agreed to pay $75 million to the families harmed. Now, Kano’s residents are reasonably hesitant of any vaccinations.

Keep reading

‘Pfizer and Moderna better get this clarified’: Study finds worse antibodies after mRNA boosters

Anew peer-reviewed study is raising concerns that a third dose of Pfizer and Moderna vaccines may actually worsen immune response against COVID-19, creating waves in both mainstream and heterodox COVID circles.

Published in Science Immunology last week, the study by German researchers found that mRNA boosting induced a high level of so-called IgG4 antibodies, a subclass known for prompting a mild immune response, in two cohorts of several dozen healthcare workers.

The “shift” to this IgG subclass was “not seen with adenovirus vector vaccines” in the study, Scripps Research Translational Institute Director Eric Topol, who was not involved in the research, tweeted while cautioning that “clinical significance is not known.” 

“Pfizer and Moderna better get this clarified,” California gastroenterologist Farid Jalali, who once pressured the FDA to fast-track COVID vaccines for infants, wrote in response to Topol before marking his account private.

The research is just the latest to prompt scrutiny of federal vaccine recommendations and ongoing professional and educational mandates, particularly for college students, a demographic with low COVID risks but elevated risks of post-jab heart inflammation.

The CDC still recommends everyone 6 months and older receive a full series and booster of the original Wuhan strain vaccine, topped off with the new bivalent Wuhan-Omicron booster, regardless of COVID risk level or likelihood of adverse reactions.

Keep reading

Israeli Ministry of Health claimed in court they were unable to locate a signed agreement with Pfizer

The Israeli Ministry of Health (“MoH”) stated before the court that it was unable to locate the agreement signed with Pfizer regarding the sharing of epidemiological information on coronavirus vaccines.  He also said that he did not know if the agreement had even been signed.

In 2020, Israel struck a deal with Pfizer, promising to share vast troves of medical data with Pfizer in exchange for the continued flow of its “hard-to-get vaccine.”  The agreement document was made public in January 2021 with large parts of it redacted. The MoH claimed last week that this agreement could not be found.

As part of an application to the Jerusalem District Court, the Ministry of Health admitted that, although an extensive search had been carried out, the agreement signed with Pfizer concerning vaccines could not be found. “We did not find a signed agreement,” said lawyer Ahava Berman of the prosecutor’s office, on behalf of MoH. “We searched all places, including the CEO’s office and the legal department”.

The claim that an agreement could not be found was made in response to a court petition after the MoH failed to respond to a request made by the Human Rights Association under the Freedom of Information Act.  The Association was attempting to establish the authenticity of the document published in January 2021 and whether or not it was signed by MoH CEO Hazi Levy and another Pfizer official whose name had been redacted.  Their signatures did not appear in the document previously released.

In a written response to the court, an MoH representative claimed that “a comprehensive inquiry has been made with many officials at the Ministry of Health to clarify whether the agreement was signed or not. Because of the government exchange and the relevant bodies in the office, the Ministry did not find out whether the agreement was signed or not.”

The petition documents were sent to Kan News and Kan News requested the information from the MoH.  Within less than a day the MoH found the signed agreement and submitted it to the court.

Keep reading

Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 Years

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the companies have submitted an application to the U.S. Food and Drug Administration (FDA) for emergency use authorization (EUA) of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine as the third 3-µg dose in the three-dose primary series for children 6 months through 4 years of age. With the high level of respiratory illnesses currently circulating among children under 5 years of age, updated COVID-19 vaccines may help prevent severe illness and hospitalization.

If authorized, children in this age group would receive a primary series consisting of two 3-µg doses of the original Pfizer-BioNTech COVID-19 Vaccine followed by a third 3-µg dose of the Omicron BA.4/BA.5-adapted bivalent vaccine. An application to extend Pfizer and BioNTech’s Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine marketing authorization in the EU to include children ages 6 months through 4 years is under discussion with the European Medicines Agency (EMA).

The Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine is currently authorized as a booster dose for ages 5 years and older in the U.S. and European Union (EU).

The Pfizer-BioNTech COVID-19 Vaccines (COMIRNATY®) are based on BioNTech’s proprietary mRNA technology and were developed by both BioNTech and Pfizer. BioNTech is the Marketing Authorization Holder for BNT162b2 (Original) and BNT162b2 Bivalent (Original/Omicron BA.4/BA.5) in the United States, the European Union, the United Kingdom, Canada and other countries, and the holder of emergency use authorizations or equivalents in the United States (jointly with Pfizer) and other countries.

Keep reading

Pfizer And Moderna To Investigate Their Own Vaccines For Myocarditis Risks

Why is Big Pharma investigating their own covid vaccines for myocarditis side effects if the vaccines were already supposedly tested and proven safe and effective?

Both Pfizer and Moderna have announced that they will be undertaking studies to determine the longer term risks of Myocarditis (an inflammatory condition of the heart which can lead to death) for people who have been injected with the mRNA based covid vaccines. The decision comes after the release of multiple medical studies which show a correlation and causation between the vaccines and an exponential increase in heart problems, specifically among men 40 years old and younger. Only a year ago the link between covid vaccinations and myocarditis was widely denied.

Studies also show that myocarditis risk increases with the number of boosters a person has taken.

Before the year 2020, the average vaccine was tested and re-tested by pharmaceutical companies and the FDA for 10 to 15 years before it could be released to the public. This was done not only because testing is a complex process with a lot of red tape involved, but also because it is the only way to discover any long term side-effects that might be associated with a particular immunization product. If you read any medical journal or scientific outline on vaccine development published before 2020, they all agree that long term testing is necessary for public safety.

Suddenly, after 2020 and the advent of public activism against the covid mandates, a host of medical “professionals” and bureaucrats began arguing that the mRNA vaccines do not need the same lengthy testing time frame because government funding allowed for everything to be accomplished much faster. This is a lie.

Keep reading

Pfizer Plans to Hike Price of US COVID-19 Vaccine by 400 Percent

Pfizer is looking to raise the price of its COVID-19 vaccines in the United States by up to four times once Washington’s purchase program ends, according to the company’s U.S. president, Angela Lukin.

Pfizer’s COVID-19 vaccine is presently provided free for all Americans by the U.S. government. Next year, when the U.S. public health emergency expires, the COVID-19 vaccine market will move to private insurance. The federal government is paying roughly $30 per dose for the Pfizer vaccine. When the government purchase program shuts down, Lukin expects a dose to be priced around $110 to $130.

“We are confident that the U.S. price point of the COVID-19 vaccine reflects its overall cost-effectiveness and ensures the price will not be a barrier for access for patients,” Lukin said, according to Reuters.

The Pfizer executive is expecting the vaccine purchase to transfer to the private sector, “at the earliest,” by first quarter 2023. According to Lukin, the vaccine will continue to be available for free for people who have government or private insurance.

In 2021, Pfizer made almost $37 billion through COVID-19 vaccine sales, with overall revenues doubling, to $81.3 billion. The company is expecting revenues to reach $98 billion to $102 billion this year.

Keep reading

Pfizer Exec Concedes COVID-19 Vaccine Was Not Tested on Preventing Transmission Before Release

A company executive admitted in a European Parliament hearing Pfizer was unsure its COVID-19 vaccine would stop transmission last year.

Pfizer’s Janine Small, president of international developed markets, acknowledged the vaccine manufacturer did not know if the vaccine would stop people from spreading coronavirus.

The Epoch Times further reported:

Roos, of the Netherlands, argued in a Twitter video Monday that following Small’s comments to him, millions of people around the world were duped by pharmaceutical companies and governments.

“Millions of people worldwide felt forced to get vaccinated because of the myth that ‘you do it for others,’” Roos said. “Now, this turned out to be a cheap lie” and “should be exposed,” he added.

Keep reading

Pfizer’s “Vaccine” Causes Astonishing Drop in Male Fertility – Men Have Not Been Informed nor Given Their Consent

When the Covid-19 vaccine rollout to the public began in late 2020, medical professionals, public health agencies, and government spokespeople all assured the public that the novel mRNA “vaccines” did not cause negative systematic effects on human bodies. They promised the public, many of whom were sceptical about the safety of a drug brought to market at “warp speed,” that the vaccines were “safe and effective.”

Those who questioned or challenged the “safe and effective” assurances were dismissed as “anti-vaxxers” and accused of wanting to kill others, especially the elderly. Few medical and public health experts spoke out about the need for long-term studies.

This attack on challengers to public health’s all-out push, and the resulting censorship of the emerging problem, resulted in catastrophic harm to male fertility.

The following is extracted from the article ‘Pfizer, FDA, CDC Hid Proven Harms to Male Sperm Quality, Testes Function, from mRNA Vaccine Ingredients’ by Amy Kelly, Program Director for the War Room/DailyClout Pfizer Documents Analysis Project as well as the COO of DailyClout.  Find more by Amy Kelly HERE.

Pfizer’s own documents and other medical studies show:

  1. Pfizer did not test “male reproductive toxicity”. Male reproductive toxicity is defined as adverse effects (negative impacts) related to sexual function and fertility in an adult male.[2]
  2. Pfizer also did not test for adverse effects from vaccinated men’s semen, on the development of their offspring.[3]
  3. mRNA vaccine ingredients travel throughout the body and gather in organs, including in the testes.[4]
  4. mRNA vaccines resulting in “anti-sperm antibodies” – that is to say, antibodies that treat sperm as an “invader”, and damage or kill it – is a known adverse event related to this form of vaccination.[5]
  5. mRNA vaccines cause a staggering drop in semen concentration and total motile count.[6]
  6. By suppressing discussion of this information, public health agencies, medical professionals, and governments globally denied and continue to deny men true informed consent.

Keep reading

Pfizer CEO pulls out of testifying to EU Parliament COVID panel

Pfizer Chief Executive Albert Bourla has pulled out of an appointment to testify before the European Parliament’s special committee on COVID-19, at which he was expected to face tough questions on how secretive vaccine deals were struck.

The decision follows an audit report into the EU’s vaccine procurement strategy published earlier in the month that raised new questions about contact between Bourla and European Commission President Ursula von der Leyen that preceded a multibillion-euro vaccine contract.

The head of the U.S. pharmaceutical giant, the largest supplier of COVID-19 vaccines to the EU, was scheduled to appear before the panel on October 10. The committee is meeting with key officials involved in the EU’s vaccine procurement process to draw lessons on how to respond to future pandemics. Other pharmaceutical executives have addressed the committee, including the CEO of Moderna and senior officials from AstraZeneca and Sanofi.

The committee’s chair, Belgian MEP Kathleen Van Brempt, told POLITICO she “deeply regrets” the decision taken by Pfizer.

Keep reading

Pfizer Bars Whites From Applying For Prestigious Fellowship

No white people need apply for Pfizer’s new “Breakthrough Fellowship” program.

From The Washington Free Beacon, “No Whites Allowed: Pfizer Fellowship Flagrantly Violates the Law, Lawyers Say”:

The pharmaceutical giant Pfizer offers a prestigious fellowship that bars whites and Asians from applying. Trumpeted on the company’s website as a “Bold Move” to “create a workplace for all,” civil rights lawyers are characterizing it in a different way: as a blatant violation of the law.

“This Pfizer program is so flagrantly illegal I seriously wonder how it passed internal review by its general counsel,” said Adam Mortara, one of the country’s top civil rights attorneys.

Pfizer’s “Breakthrough Fellowship” offers college students multiple internships, a fully funded master’s degree, and several years of employment at the pharmaceutical giant. It also restricts applications to “Black/African American, Latino/Hispanic and Native American” students, the fellowship requirements state.

In a Frequently Asked Questions brochure about the nine-year program, Pfizer asserts that it is an “equal opportunity employer.”

Keep reading